From Novogen website about Iain Ross Iain Ross
Post# of 30028
Posted On: 08/30/2014 12:02:16 AM
From Novogen website about Iain Ross
Iain Ross, based in the UK, is an experienced director on a number of Australian company boards including Benitec Biopharma Ltd and Tissue Therapies Ltd .
He is also currently Chairman of Ark Therapeutics plc, listed in London and a director of a number of other European based technology companies. In his career he has held senior positions at Coms plc, Sandoz AG, Fisons plc, Hoffmann-La Roche AG, and Celltech Group Plc and also undertaken a number of start-ups and turnarounds on behalf of banks and private equity groups.
His track record includes multiple financing transactions having raised >£300m, both publicly and privately, as well as extensive experience of divestments and strategic restructurings and >20 years in cross-border management as a Chairman and CEO. He has led and participated in 4 LSE Initial Public Offerings, and has direct experience of M&A transactions in Europe, USA and the Pacific Rim.
He is a qualified Chartered Director and Vice Chairman of the Council of Royal Holloway, London University.
Iain Ross, based in the UK, is an experienced director on a number of Australian company boards including Benitec Biopharma Ltd and Tissue Therapies Ltd .
He is also currently Chairman of Ark Therapeutics plc, listed in London and a director of a number of other European based technology companies. In his career he has held senior positions at Coms plc, Sandoz AG, Fisons plc, Hoffmann-La Roche AG, and Celltech Group Plc and also undertaken a number of start-ups and turnarounds on behalf of banks and private equity groups.
His track record includes multiple financing transactions having raised >£300m, both publicly and privately, as well as extensive experience of divestments and strategic restructurings and >20 years in cross-border management as a Chairman and CEO. He has led and participated in 4 LSE Initial Public Offerings, and has direct experience of M&A transactions in Europe, USA and the Pacific Rim.
He is a qualified Chartered Director and Vice Chairman of the Council of Royal Holloway, London University.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼